Dr. Murali K. Divi

Managing Director

The global Active Pharmaceutical Ingredients (API) market was valued at $209.7 billion last year and the industry is expected to clock in a CAGR of six percent between 2022 and 2030. Things are similar in India as well where the API market value reached USD 18 billion last year. Apart from the advancements made in the API market, the increasing number of chronic illnesses including cardiovascular diseases and cancer can be attributed to this growth. Divi’s Laboratories is one of the leading names in the Indian API market and it has the world’s largest API manufacturing facility. Operating out of Hyderabad, Divi’s Laboratories has been able to develop into one of the most notable names in not just the Indian API market but across the globe and today, the company offers world class products to more than 95 countries.

Global Leader in API Manufacturing

Being committed to never compromise on the quality of the offerings, Divi’s Laboratories has been able to rank amongst the top API manufacturers in the world. The company continues to be a global leader in large volume generic APIs with an impressive product portfolio of 30 APIs that are manufactured commercially. Apart from this, Divi’s Laboratories also has 10 APIs which are in different phases of research and development. Starting from backward integration to basic starting materials and dedicated production blocks, there are multiple facets which have all helped the company carve a niche for themselves in the global API manufacturing domain.

Driven by passion for consistent improvement, Divi’s Laboratories is accelerating its growth as an internationally recognized reliable supplier of APIs that can offer products which have uniform quality and are competitively priced. Apart from APIs, Divi’s Laboratories also has two other product segments including Nutraceuticals where the company offers the complete array of Carotenoids including Beta Carotene, Lycopene, and so on and finished forms such as Lutein. In the custom synthesis segment, Divi’s Laboratories has showcased its ability to handle energetic reactions with high potency which has helped it cater to even the most demanding requirements from big pharma companies.

Going the Extra Mile to Ensure Consistent Quality

Divi’s Laboratories acknowledges the importance of having the right infrastructure to produce world class goods ofconsistent quality. The company has two world class manufacturing facilities in Hyderabad and Vizag which have been inspected by FDA, EU GMP, TGA, PMDA and MFDS health authorities. Research and development is another important facet of the company’s operations and their R&D team is engaged in the development of best in class processes which can accelerate the company’s growth and help them be frontrunners when it comes to research and innovation in the industry.

Also, more than 2100 of their employees are working on ensuring the consistent quality of their products which has helped Divi’s Laboratories create a robust quality control system. These employees are backed by cutting edge technologies including analytical instruments to streamline and enhance the efficiency of their quality control procedures. Evolving with the changing times, Divi`s Laboratories has no intention to rest on its laurels. Instead, the company aspires to be a catalyst of change in the global pharma industry.